Generated by GPT-5-mini| ETH Zurich Technology Transfer | |
|---|---|
| Name | ETH Zurich Technology Transfer |
| Founded | 2003 |
| Location | Zurich, Switzerland |
| Parent | Swiss Federal Institute of Technology in Zurich |
| Type | Technology transfer office |
ETH Zurich Technology Transfer
ETH Zurich Technology Transfer is the technology transfer office associated with the Swiss Federal Institute of Technology in Zurich, facilitating translational research, intellectual property management, and commercialization of innovations developed at ETH Zurich. It connects researchers with venture capital investors, industry partners such as Siemens, Novartis, and Roche, and supports founding teams in creating start-up companies, while coordinating with Swiss and international funding bodies like the European Research Council, Innosuisse, and the European Investment Bank.
ETH Zurich Technology Transfer operates as the central commercialization and spin-off facilitation unit for ETH Zurich, interfacing with academic units such as the Department of Mechanical and Process Engineering, Department of Computer Science, Department of Physics, and Department of Chemistry and Applied Biosciences. It provides services spanning patent filing with law firms, licensing agreements with multinational corporations including ABB and GlaxoSmithKline, and connections to incubators like ETH Zurich Spin-Off Fund and accelerators such as MassChallenge and Y Combinator. The office collaborates with public institutions including the Swiss National Science Foundation and private entities including Goldman Sachs and Index Ventures.
The office was established as part of ETH Zurich's strategic push to increase technology transfer following examples set by institutions like Stanford University, Massachusetts Institute of Technology, University of Cambridge, and Imperial College London. Early milestones involved licensing agreements with companies such as ABB and research collaborations with IBM and Microsoft. Over time, the unit expanded services to cover biotechnology and nanotechnology projects, influenced by partnerships with organizations like Novartis Institutes for BioMedical Research and infrastructures such as Paul Scherrer Institute. The development trajectory mirrored broader European trends exemplified by the Lisbon Strategy and programs under the Horizon 2020 framework.
Services include invention disclosure management, patent prosecution coordination with firms like Dentons and Allen & Overy, market assessment studies engaging consultancies such as McKinsey & Company and BCG, and negotiation of collaborative research agreements with corporations including Siemens Healthineers and Roche Diagnostics. The office organizes entrepreneurship training with partners like ETH Entrepreneur Club, hosts investor pitch events attracting Sequoia Capital and Accel Partners, and provides access to facilities including ETH Zurich Research Collection and shared labs at Technopark Zurich. It also supports compliance with grant frameworks administered by European Commission bodies and Swiss agencies.
ETH Zurich Technology Transfer manages patent portfolios arising from researchers such as recipients of the Fields Medal, Turing Award, and Nobel Prize laureates affiliated with ETH Zurich. It works with patent attorneys and international offices including the European Patent Office and the World Intellectual Property Organization to file and prosecute patents, negotiate exclusive and non-exclusive licenses with companies like Philips and BASF, and handle revenue-sharing agreements involving ETH spin-offs and investors including Swisscom Ventures and EPFL Innovation Park collaborators. The office implements commercialization strategies influenced by case studies from Harvard University and Yale University technology transfer models.
Support for start-ups includes mentorship programs with alumni networks and founders associated with Google, Facebook, and Amazon, seed financing coordination via the ETH Zurich Foundation and the Venture Kick program, and incubation space in ecosystems like Zurich West and Science City. ETH spin-offs that received support include ventures collaborating with CERN, Fraunhofer Society, and Johnson & Johnson. The office also facilitates connections to corporate venture arms such as Intel Capital and Bayer Growth Ventures and organizes participation in conferences like Web Summit, Slush, and SXSW.
Strategic partnerships span multinational firms, academic institutions, and research organizations: collaborations with Siemens, ABB, Roche, Novartis, IBM Research, Microsoft Research, ETH Zurich's Competence Centers, and international universities including École Polytechnique Fédérale de Lausanne and University of Oxford. The office manages contractual frameworks for joint research centers, sponsored chairs with industry partners, and consortium participation in projects funded by Horizon Europe and bilateral programs with countries such as United States and Japan.
The office has contributed to the creation of numerous spin-offs and licensed technologies across sectors like medtech, cleantech, robotics, and quantum computing—including collaborations that engaged IBM Quantum, Google Quantum AI, and Microsoft Quantum. Notable projects include commercialization pathways for sensor technologies used by ABB Robotics and pharmaceutical delivery platforms licensed to Novartis. Its impact is evidenced by metrics comparable to those reported by Stanford Office of Technology Licensing and MIT Technology Licensing Office in terms of start-up formation, patent filings, and licensing income, and its activities feed into Swiss innovation ecosystems involving Innosuisse and the Swiss Innovation Park.
Category:ETH Zurich Category:Technology transfer offices